What’s happening with specialised commissioning in the NHS? How likely is a delay in delegation to integrated care boards (ICBs)? How and what should Pharma and Medtech plan for amidst...
Read More
What is the EU Joint Clinical Assessment (JCA) and what does it mean for market access and reimbursment in Euorpe?
We are delighted to announce that the second edition of our popular introductory guide: ‘Market access and reimbursement in key European markets’ is now available. Our market access experts have...
Read More
What does it take to run a truly patient-centric integrated health system? What does the Welsh journey with integration tell us about the future for England? Paul Mears (CEO, Cwm...
Read More
We’re delighted to announce that we will be exhibiting at ISPOR Europe in Copenhagen over the 13th–15th November 2023. Visit our virtual booth Meet the team Research & Posters Meet...
Read More
How can the life sciences industry and the NHS work together to deliver real change? An overview of the key themes from our 2023 NHS Transformation Symposium.
Richard Marsh reflects on key themes from our NHS Transformation Symposium. He explores the operational and strategic challenges facing the NHS, the historic focus on inputs rather than outputs and the call put our by all our NHS speakers for a more collaborative relationship with and across industry.
For our Global Whispers webinar in October, Clare Foy (Director – Global Market Access, Mtech Access) spoke to Italian market access expert Prof. Fabrizio Gianfrate (Professor of Health Economics and...
Read More
What does NHS primary care need from industry? In our October NHS Whispers webinar, Dr Farzana Hussain (GP Principal, The Project Surgery) and Prof. Phil Richardson (Chair and Chief Innovation...
Read More
Richard Johnson (Senior Management Consultant – Innovation, Mtech Access) explores the potential of AI in healthcare and life sciences sectors.
